Unlock open and closed claims data with taXOnomy: Claim better outreach
In the evolving world of real-world data (RWD), pharmaceutical companies are increasingly focused...
In the evolving world of real-world data (RWD), pharmaceutical companies are increasingly focused...
In our series exploring the benefits, considerations and use cases for various types of real-world...
Background of the CRWDi project While the COVID-19 pandemic is behind us, the virus remains a...
The healthcare industry has moved away from paper charts and file folders in favor of electronic...
As high-value therapies become the new norm,life sciences teams need closed claims data that...
Open claims and closed payer claims data are essential for understanding the status and activities...
The FDA often requires some sort of post-market surveillance for medical devices to determine the...
Real-world data (RWD) offers a multitude of use cases that can benefit pharmaceutical companies...
Our series exploring the value of real-world data (RWD) throughout the pharmaceutical product life...
In our ongoing series, we have been discussing the value of real-world data (RWD) throughout the...
A better way to measure healthcare costs in closed claims data This is the second post in our four-part taXonomy X blog series (part 1 here), and here we’ll discuss one of the most common pain points in closed claims analytics: costs. Specifically, w...